Senior Executive with extensive knowledge and experience in oncology drug development. Over 20 years in oncology care and drug development across a broad platform of solid tumor and hematologic indications and drug types. Strategic thinker coupled with tactical experience across the oncology drug development landscape. Experience in small biotech and large pharma industry domains, with knowledge of asset valuation, global drug development, risk management and organizational efficiency.
